首页|冠状动脉病变分型与冠状动脉非靶病变进展和血运重建的关系

冠状动脉病变分型与冠状动脉非靶病变进展和血运重建的关系

扫码查看
目的:研究冠状动脉(冠脉)病变分型与冠心病患者冠脉非靶病变进展和血运重建的关系.方法:回顾性分析中国医学科学院阜外医院2010年1月至2014年9月期间,接受连续2次冠脉造影检查且造影发现冠脉非靶病变的冠心病患者1255例.患者均在第1次冠脉造影时记录到了至少1处冠脉非靶病变,所有患者均在2年内完成2次冠脉造影检查,非靶病变根据美国心脏病学会/美国心脏协会(ACC/AHA)冠脉病变分型分为A/B1型病变,B2/C型病变,依据患者非靶病变是否有B2/C型病变分为无B2/C型病变(简单病变组)和有B2/C型病变(复杂病变组).记录所有冠脉非靶病变的特征和定量冠脉造影结果并进行前后2次对比,判断冠脉非靶病变是否进展,并记录患者的血运重建情况.结果:共纳入1255例患者,男性1003例(79.9%),年龄(58.0±9.7)岁.其中简单病变组402例,复杂病变组853例;共有1670处非靶病变,其中A/B1型病变619处(A型病变214处,B1型病变405处)和B2/C型病变1051处(B2型病变796处,C型病变255处).随访(14.8±4.5)个月.与简单病变组相比,复杂病变组年龄较大,冠心病家族史及合并脑卒中病史比例均较低(P均<0.05).复杂病变组患者基线白细胞计数、C反应蛋白、血沉、甘油三酯、糖化血红蛋白水平均较简单病变组高(P均<0.05).复杂病变组的非靶病变进展比例(21.8%vs.13.2%,P<0.001)和非靶病变血运重建比例(16.5%vs.11.2%,P=0.013)均高于简单病变组.两组的非靶病变相关心肌梗死发生率的差异无统计学意义(P>0.05).在病变水平,复杂病变组较简单病变组非靶病变进展比例更高(17.4%vs.11.0%,P<0.001),非靶病变血运重建比例更高(13.0%vs.9.2%,P=0.018).多因素Cox回归分析显示,B2/C型病变是非靶病变进展(HR=1.732,95%CI:1.275~2.351,P<0.001)和非靶病变血运重建(HR=1.477,95%CI:1.053~2.070,P=0.024)的独立影响因素.结论:冠脉非靶病变B2/C型病变的进展风险更大,血运重建风险更高,应更严格控制危险因素,警惕病变进展所引起的不良心血管事件.
Impacts of Lesion Classification on the Progression and Revascularization of Coronary Non-target Lesions in Patients With Coronary Heart Disease
Objectives:To investigate the impacts of American College of Cardiology/American Heart Association (ACC/AHA) coronary artery classification on the progression of coronary non-target lesions and revascularization in patients with coronary heart disease.Methods:From January 2010 to September 2014,1255 patients who underwent two consecutive coronary angiographies at Fuwai Hospital and had coronary non-target lesions were retrospectively analyzed.Lesion characteristics of all coronary non-target lesions were recorded at both procedures.All non-target lesions were divided into A,B1,B2 and C lesion group according to ACC/AHA coronary artery classification.Patients were divided into non-B2/C lesion group (noncomplex lesion group) and B2/C lesion group (complex lesion group) according to whether the non-target lesion had B2/C lesion The characteristics of all non-target coronary artery lesions and quantitative coronary angiography results were recorded.Lesion progression and revascularization were compared between different groups.Results:There were 1003 (79.9%) male patients,mean age was (58.0±9.7) years old,and 853 patients had B2/C lesions.There were 1670 non-target lesions,including 619 A/B1 lesions (214 A lesions and 405 B1 lesions) and 1051 B2/C lesions (796 B2 lesions and 255 C lesions).Follow-up time was (14.8±4.5) months.Compared with the patients in noncomplex lesion group,patients in complex lesion group were older,had lower proportion of family history of coronary heart disease and stroke (all P<0.05).The baseline levels of leukocytes,C-reactive protein,erythrocyte sedimentation rate (ESR),triglyceride and HbA1c were higher in complex lesion group than those in noncomplex lesion group.Complex lesion group had higher risk of lesion progression (21.8% vs.13.2%,P<0.001) compared with noncomplex lesion group,similar results were observed in revascularization (16.5% vs.11.2%,P=0.013),and there was no statistically difference in non-target lesion related myocardial infarction (P>0.05).At the lesion level,compared with A/B1 lesion,B2/C lesion was associated with a higher rate of lesion progression (17.4% vs.11.0%,P<0.001),and a higher rate of revascularization (13.0% vs.9.2%,P=0.018).Multivariate Cox regression analysis showed that lesion classification (B2/C) was an independent risk factor for non-target lesion progression (HR=1.732,95%CI:1.275-2.351,P<0.001) and non-target lesion revascularization (HR=1.477,95%CI:1.053-2.070,P=0.024).Conclusions:The risk of non-target lesion progression and revascularization is higher in complex groups compared with noncomplex groups according to ACC/AHA classification.So patients with complex lesions should receive more strict medical care to control related risk factors and improve their outcome.

ACC/AHA coronary artery classificationcoronary non-target lesionlesion progressionrevascularization

闫森、许浩博、黄晓青、张海鹏、陈纪林、乔树宾、崔锦钢、高立建、党爱民、管常东、张炜、李佐治、王娟

展开 >

中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 心内科,北京 100037

美国心脏病学会/美国心脏协会冠状动脉病变分型 冠状动脉非靶病变 病变进展 血运重建

2024

中国循环杂志
中国医学科学院

中国循环杂志

CSTPCD北大核心
影响因子:2.803
ISSN:1000-3614
年,卷(期):2024.39(12)